Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Cryptosporidium parvum and related species are zoonotic intracellular parasites of the intestine. Cryptosporidium is a leading cause of diarrhea in small children around the world. Infection can cause severe pathology in children and immunocompromised patients. This waterborne parasite is resistant to common methods of water treatment and therefore a prominent threat to drinking and recreation water even in countries with strong water safety systems. The drugs currently used to combat these organisms are ineffective. Genomic analysis revealed that the parasite relies solely on inosine-5'-monophosphate dehydrogenase (IMPDH) for the biosynthesis of guanine nucleotides. Herein, we report a selective urea-based inhibitor of C. parvum IMPDH (CpIMPDH) identified by high-throughput screening. We performed a SAR study of these inhibitors with some analogues exhibiting high potency (IC(50) < 2 nM) against CpIMPDH, excellent selectivity >1000-fold versus human IMPDH type 2 and good stability in mouse liver microsomes. A subset of inhibitors also displayed potent antiparasitic activity in a Toxoplasma gondii model.

[1]  L. Hedstrom,et al.  Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. , 2012, Bioorganic & medicinal chemistry letters.

[2]  Edward H. Kerns,et al.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery , 2010, Nature Reviews Drug Discovery.

[3]  L. Hedstrom,et al.  A Screening Pipeline for Antiparasitic Agents Targeting Cryptosporidium Inosine Monophosphate Dehydrogenase , 2010, PLoS neglected tropical diseases.

[4]  L. Hedstrom,et al.  The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity. , 2010, Journal of the American Chemical Society.

[5]  L. Hedstrom,et al.  Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. , 2009, Journal of medicinal chemistry.

[6]  L. Hedstrom.  IMP dehydrogenase: structure, mechanism, and inhibition. , 2009, Chemical reviews.

[7]  M. Balcı,et al.  The Chemistry of Homophthalic Acid: A New Synthetic Strategy for Construction of Substituted Isocoumarin and Indole Skeletons. , 2008 .

[8]  S. Ramani,et al.  Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. , 2008, Journal of medical microbiology.

[9]  S. Moore,et al.  Malnutrition as an enteric infectious disease with long-term effects on child development. , 2008, Nutrition reviews.

[10]  Lisa Sharling,et al.  Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. , 2008, Chemistry & biology.

[11]  A. Meijere,et al.  Addition of organometallic reagents to nitriles promoted by titanium(IV) isopropoxide as a procedure of synthesis of primary tert-alkylamines , 2007 .

[12]  A. J. Kennan,et al.  Facile production of mono-substituted urea side chains in solid phase peptide synthesis. , 2007, Biopolymers.

[13]  V. Larue,et al.  Discovery and refinement of a new structural class of potent peptide deformylase inhibitors. , 2007, Journal of medicinal chemistry.

[14]  R. Guerrant,et al.  Cryptosporidium species: preliminary descriptions of the prevalence and genotype distribution among school children and hospital patients in the Venda region, Limpopo Province, South Africa. , 2006, Experimental parasitology.

[15]  A. White,et al.  An updated review on Cryptosporidium and Giardia. , 2006, Gastroenterology clinics of North America.

[16]  R. Fayer,et al.  Cryptosporidium: a water-borne zoonotic parasite. , 2004, Veterinary parasitology.

[17]  Gregory A. Buck,et al.  The genome of Cryptosporidium hominis , 2004, Nature.

[18]  L. Hedstrom,et al.  Cryptosporidium parvum IMP Dehydrogenase , 2004, Journal of Biological Chemistry.

[19]  Ping Xu,et al.  Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum , 2004, Science.

[20]  J. Trevors,et al.  Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. , 2004, Water research.

[21]  L. Hedstrom,et al.  Cryptosporidium parvum IMP Dehydrogenase IDENTIFICATION OF FUNCTIONAL, STRUCTURAL, AND DYNAMIC PROPERTIES THAT CAN BE EXPLOITED FOR DRUG DESIGN* , 2004 .

[22]  P. Bertus,et al.  A direct synthesis of 1-aryl- and 1-alkenylcyclopropylamines from aryl and alkenyl nitriles. , 2003, The Journal of organic chemistry.

[23]  J. Logsdon,et al.  Genetic complementation in apicomplexan parasites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. L. Dall'Oglio,et al.  PREPARATION OF AROMATIC ETHERS AND DIOXOLANES UNDER MICROWAVE IRRADIATION , 2001 .

[25]  J J Tolboom,et al.  The infectivity of Cryptosporidium parvum in healthy volunteers. , 1996, Journal of pediatric gastroenterology and nutrition.

[26]  J. P. Davis,et al.  A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. , 1994, The New England journal of medicine.

[27]  E. H. White,et al.  N-Nitrososulfamates: Sources of Carbonium Ions in Aqueous Media and Substrates in Solid-State Decompositions , 1992 .

[28]  T. Hase,et al.  A Non-Organometallic Method for the Synthesis of Methyl Ketones from Acyl Chlorides , 1980 .